Viruses are master builders — and now we know their secret. Oxford researchers have captured, for the first time, virus-like particles assembling themselves molecule by molecule, revealing a surprisingly elegant trial-and-error process. The discovery, published in Nature, could unlock new antiviral drugs and smarter vaccine designs.
Viruses are master builders — and now we know their secret. Oxford researchers have captured, for the first time, virus-like particles assembling themselves molecule by molecule, revealing a surprisingly elegant trial-and-error process. Published in Nature, the study shows that viral protein shells (called capsids) don't follow a blueprint — instead, they rely on weak, reversible connections that allow failed attempts to fall apart and try again, until the right arrangement locks into place.
The key breakthrough? Identifying a crucial molecular turning point: when five protein building blocks form a closed pentagonal ring — the first truly stable structure in the process. From that point on, assembly accelerates, with each new stable stage requiring fewer additional components to reach completion. The team used mass photometry — a technique developed at Oxford — combined with a new molecule-confinement method to "weigh" individual particles in real time as they grew, essentially filming the construction process.
Key Takeaways:
Why it matters: Understanding the precise rules of viral self-assembly opens a new front in antiviral drug development — and could reshape how scientists engineer vaccines and biological therapies.
